PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
TRIP vs. NPCE
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between TRIP and NPCE is 0.19, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.2

Performance

TRIP vs. NPCE - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in TripAdvisor, Inc. (TRIP) and NeuroPace, Inc. (NPCE). The values are adjusted to include any dividend payments, if applicable.

-20.00%0.00%20.00%40.00%60.00%AugustSeptemberOctoberNovemberDecember2025
-10.63%
56.48%
TRIP
NPCE

Key characteristics

Sharpe Ratio

TRIP:

-0.39

NPCE:

-0.10

Sortino Ratio

TRIP:

-0.19

NPCE:

0.45

Omega Ratio

TRIP:

0.97

NPCE:

1.06

Calmar Ratio

TRIP:

-0.22

NPCE:

-0.10

Martin Ratio

TRIP:

-0.51

NPCE:

-0.17

Ulcer Index

TRIP:

37.99%

NPCE:

46.53%

Daily Std Dev

TRIP:

50.11%

NPCE:

80.72%

Max Drawdown

TRIP:

-86.79%

NPCE:

-95.13%

Current Drawdown

TRIP:

-83.64%

NPCE:

-54.83%

Fundamentals

Market Cap

TRIP:

$2.18B

NPCE:

$357.28M

EPS

TRIP:

$0.27

NPCE:

-$0.99

Total Revenue (TTM)

TRIP:

$1.42B

NPCE:

$58.44M

Gross Profit (TTM)

TRIP:

$1.25B

NPCE:

$42.90M

EBITDA (TTM)

TRIP:

$187.00M

NPCE:

-$13.97M

Returns By Period

In the year-to-date period, TRIP achieves a 8.53% return, which is significantly higher than NPCE's 6.97% return.


TRIP

YTD

8.53%

1M

23.78%

6M

-9.28%

1Y

-20.92%

5Y*

-12.35%

10Y*

-12.61%

NPCE

YTD

6.97%

1M

3.82%

6M

56.47%

1Y

-16.24%

5Y*

N/A

10Y*

N/A

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

TRIP vs. NPCE — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

TRIP
The Risk-Adjusted Performance Rank of TRIP is 2929
Overall Rank
The Sharpe Ratio Rank of TRIP is 2626
Sharpe Ratio Rank
The Sortino Ratio Rank of TRIP is 2727
Sortino Ratio Rank
The Omega Ratio Rank of TRIP is 2525
Omega Ratio Rank
The Calmar Ratio Rank of TRIP is 3232
Calmar Ratio Rank
The Martin Ratio Rank of TRIP is 3636
Martin Ratio Rank

NPCE
The Risk-Adjusted Performance Rank of NPCE is 4242
Overall Rank
The Sharpe Ratio Rank of NPCE is 4040
Sharpe Ratio Rank
The Sortino Ratio Rank of NPCE is 4444
Sortino Ratio Rank
The Omega Ratio Rank of NPCE is 4444
Omega Ratio Rank
The Calmar Ratio Rank of NPCE is 4040
Calmar Ratio Rank
The Martin Ratio Rank of NPCE is 4242
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

TRIP vs. NPCE - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for TripAdvisor, Inc. (TRIP) and NeuroPace, Inc. (NPCE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for TRIP, currently valued at -0.39, compared to the broader market-2.000.002.004.00-0.39-0.10
The chart of Sortino ratio for TRIP, currently valued at -0.19, compared to the broader market-4.00-2.000.002.004.00-0.190.45
The chart of Omega ratio for TRIP, currently valued at 0.97, compared to the broader market0.501.001.502.000.971.06
The chart of Calmar ratio for TRIP, currently valued at -0.26, compared to the broader market0.002.004.006.00-0.26-0.10
The chart of Martin ratio for TRIP, currently valued at -0.51, compared to the broader market-10.000.0010.0020.0030.00-0.51-0.17
TRIP
NPCE

The current TRIP Sharpe Ratio is -0.39, which is lower than the NPCE Sharpe Ratio of -0.10. The chart below compares the historical Sharpe Ratios of TRIP and NPCE, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-0.500.000.501.00AugustSeptemberOctoberNovemberDecember2025
-0.39
-0.10
TRIP
NPCE

Dividends

TRIP vs. NPCE - Dividend Comparison

Neither TRIP nor NPCE has paid dividends to shareholders.


TTM202420232022202120202019
TRIP
TripAdvisor, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%11.52%
NPCE
NeuroPace, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Drawdowns

TRIP vs. NPCE - Drawdown Comparison

The maximum TRIP drawdown since its inception was -86.79%, smaller than the maximum NPCE drawdown of -95.13%. Use the drawdown chart below to compare losses from any high point for TRIP and NPCE. For additional features, visit the drawdowns tool.


-75.00%-70.00%-65.00%-60.00%-55.00%AugustSeptemberOctoberNovemberDecember2025
-68.56%
-54.83%
TRIP
NPCE

Volatility

TRIP vs. NPCE - Volatility Comparison

The current volatility for TripAdvisor, Inc. (TRIP) is 12.69%, while NeuroPace, Inc. (NPCE) has a volatility of 15.03%. This indicates that TRIP experiences smaller price fluctuations and is considered to be less risky than NPCE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


0.00%10.00%20.00%30.00%40.00%AugustSeptemberOctoberNovemberDecember2025
12.69%
15.03%
TRIP
NPCE

Financials

TRIP vs. NPCE - Financials Comparison

This section allows you to compare key financial metrics between TripAdvisor, Inc. and NeuroPace, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab